Hormone Regulated Cancers

I. Introduction to Nuclear Hormone Receptors

  • Definition: Nuclear hormone receptors (NHRs) are a class of proteins within cells that are responsible for sensing steroid and thyroid hormones and certain cellular non-steroid hormones.

  • Types of Ligands: NHRs have specific ligands that can activate or inhibit their function, which include hormones such as estradiol and testosterone.

II. Function of NHRs

A. Mechanism of Action

  • NHRs mediate transcriptional regulation by binding to specific DNA sequences called hormone response elements (HREs).

  • Upon hormone binding to the receptor, a conformational change occurs that influences gene expression and protein synthesis.

B. Examples of NHRs in Cancer

1. Leukemia and Glucocorticoid Receptor

  • Glucocorticoid receptors play a crucial role in tumor suppression and the treatment of leukemia through their function in inducing apoptosis in white blood cells.

2. Breast Cancer and Estrogen Receptor

  • Estrogen receptors mediate the effects of estrogens and are implicated in the regulation and growth of breast cancer cells.

3. Prostate Cancer and Androgen Receptor

  • Androgen receptors are involved in prostate cancer progression and are a target for therapeutic intervention.

III. Breast Cancer and Estrogen Receptor

A. Molecular Basis of Estrogen Function

  • Estrogen’s Role: Estrogen (17β-estradiol, E2) is critical not only for reproduction but also has significant roles in various systems including cardiovascular and immune systems.

  • Implications in Cancer: Increased estrogen levels are associated with breast cancer development and progression.

B. Functional Domains of ER

  • DNA-binding Domain (DBD): Required for binding to specific DNA sequences.

  • Ligand-binding Domain (LBD): Responsible for the binding of the receptor to estrogen.

C. Selective Estrogen Receptor Modulators (SERMs)

  • SERMs show different tissue-selective actions due to their ability to induce distinct conformational changes in ER, acting as agonists in some tissues and antagonists in others.

IV. Prostate Cancer and Androgen Receptor

A. Mechanism of Androgen Action

  • Androgens, particularly dihydrotestosterone (DHT), bind to androgen receptors leading to transcription of genes that promote prostate growth.

B. Prostate Cancer Biomarkers

  • Prostate-Specific Antigen (PSA): A key biomarker used to screen for prostate cancer and monitor treatment response.

C. Prostate Cancer Therapy

  • Hormonal Therapies: Treatments include androgen deprivation therapy (ADT), targeting the hormonal pathways involved in cancer progression.

  • Mechanisms of Resistance: Prostate cancer can become resistant to hormonal therapies through various mutations and alterations in androgen receptor signaling.

V. Conclusion and Learning Objectives

  • Understanding the molecular mechanisms of NHRs in relation to cancer can aid in developing therapeutic strategies.

  • Objectives include demonstrating drug actions, describing drug targets in the endocrine system, and integrating pharmacological knowledge for clinical decision-making.

Flashcards on Nuclear Hormone Receptors

  1. Nuclear Hormone Receptors (NHRs): Proteins that sense steroid and thyroid hormones and certain non-steroid hormones.

  2. Function of NHRs: Mediate transcriptional regulation by binding to hormone response elements (HREs), influencing gene expression.

  3. Glucocorticoid Receptor in Leukemia: Plays a role in tumor suppression and induces apoptosis in white blood cells.

  4. Estrogen Receptor in Breast Cancer: Mediates the effects of estrogens and is involved in breast cancer regulation and growth.

  5. Androgen Receptor in Prostate Cancer: Involved in prostate cancer progression and targeted for therapy.

  6. Selective Estrogen Receptor Modulators (SERMs): These compounds have different tissue-selective actions, acting as agonists or antagonists.

  7. Prostate-Specific Antigen (PSA): A biomarker for screening and monitoring prostate cancer treatment.

  8. Hormonal Therapies for Prostate Cancer: Treatments aimed at disrupting hormonal pathways that enable cancer progression.

Go Back

Definition: The term 'go back' typically refers to the action of returning to a previous place, state, or situation.

Contextual Uses:

  1. Navigation: In the context of web browsing or software applications, 'go back' is an action that allows users to return to a previous page or step in a process.

  2. Personal Reflection: In conversations, 'go back' might refer to revisiting past experiences or decisions for analysis or discussion.

  3. Physical Movement: It can refer to physically retracing one's steps to a prior location.

Importance: The concept of going back is significant in various fields such as computing, psychology, and travel, as it emphasizes the necessity of understanding past actions and choices.